Clinical Trials on Hemophilia A in Singapore
Total 79 results
-
BayerCompletedHemophilia A, Hemophilia BItaly, China, New Zealand, Russian Federation, Taiwan, Singapore, Bulgaria, United States, Denmark, Germany, Hungary, South Africa, United Kingdom, Romania, Colombia, Mexico, Turkey, France, India, Japan, Australia, Netherlands, Poland and more
-
PfizerCompletedHemophilia BCanada, Singapore, Turkey, Croatia, Korea, Republic of, Mexico, Poland, Bulgaria, Malaysia
-
Christian Medical College, Vellore, IndiaUnknownHemophiliaIndia, Argentina, Brazil, Egypt, Iran, Islamic Republic of, Singapore, South Africa, Thailand, Venezuela
-
SingHealth PolyclinicsCompletedAdvanced Medical Directive, a Legal Document Signed in Advance to State Healthcare PreferencesSingapore
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Active, not recruitingHemophilia ASpain, United States, Denmark, Italy, Taiwan, Malaysia, Belgium, Thailand, Turkey, Austria, Bulgaria, Canada, Finland, France, Germany, Hong Kong, Hungary, Korea, Republic of, Netherlands, Norway, Singapore, Ukraine, United Kingdom
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia ASpain, United States, Australia, Singapore, Taiwan, Hong Kong, Malaysia, Bulgaria, United Kingdom, Switzerland, Ukraine, Turkey, Italy, Norway, France, Austria, Romania, Sweden, Poland, Germany, Hungary, Israel
-
BayerCompletedHemophilia AKorea, Republic of, Taiwan, Turkey, Singapore, United States, Netherlands, Austria, Denmark, United Kingdom, Belgium, Italy, France, Japan, Germany, Israel, Poland, Canada, Norway, Romania, Colombia
-
National University Hospital, SingaporeNational University Cancer Institute, Singapore (NCIS)UnknownThe Effect of a Psycho-education Support Group TherapySingapore
-
Changi General HospitalNot yet recruitingCardiovascular Diseases | Hypercholesterolemia | Lipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaSingapore
-
Changi General HospitalCompleted
-
Singapore Clinical Research InstituteSingapore General Hospital; Duke-NUS Graduate Medical SchoolTerminatedAssess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.Singapore
-
National University Hospital, SingaporeUnknown
-
F-star Therapeutics, Inc.CSI Medical Research Pte LtdTerminatedHepatitis B | Hepatitis B, Chronic | HBVSingapore
-
Changi General HospitalNational University Hospital, SingaporeCompleted
-
Seng Gee LimSingapore General Hospital; Tan Tock Seng Hospital; Changi General HospitalUnknown
-
Seng Gee LimNational Medical Research Council (NMRC), Singapore; Singapore Clinical Research...UnknownChronic Hepatitis BSingapore
-
Seng Gee LimMerck Sharp & Dohme LLC; Singapore General Hospital; Tan Tock Seng Hospital; Changi... and other collaboratorsCompleted
-
Romark Laboratories L.C.CompletedChronic Hepatitis BSingapore
-
Seng Gee LimRoche Pharma AGUnknownChronic Hepatitis, B Virus | Carrier of Viral Hepatitis Type BSingapore
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Mina Alpha LimitedActive, not recruitingHepatitis B | Hepatocellular Carcinoma | Hepatitis CSingapore, United States
-
PfizerCompletedSolid Tumors Harboring a BRAF V600 MutationUnited States, France, Italy, Singapore, Australia, Spain, Switzerland, Canada, Belgium
-
Janssen Research & Development, LLCTerminated
-
SCG Cell Therapy Pte. Ltd.RecruitingHepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular CarcinomaUnited States, Singapore, Hong Kong
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Hoffmann-La RocheCompletedHepatitis B, ChronicTaiwan, United States, New Zealand, Singapore
-
Hoffmann-La RocheCompletedHepatitis B, ChronicTaiwan, United States, New Zealand, Singapore
-
Triangle PharmaceuticalsUnknownHepatitis BUnited States, Canada, China, France, Singapore
-
PowderMedCompletedChronic Hepatitis BThailand, Hong Kong, Singapore, Taiwan
-
Boston Scientific CorporationCompletedBiliary Stricture | Periampullary Tumor | Biliary Obstruction Due to Common Bile Duct Stone | HemobiliaHong Kong, Korea, Republic of, Thailand, Australia, Saudi Arabia, Japan, India, Pakistan, Singapore, South Africa
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BUnited States, Taiwan, Singapore, Korea, Republic of, China
-
Hoffmann-La RocheCompletedHepatitis B, ChronicKorea, Republic of, Taiwan, Hong Kong, Malaysia, Singapore, New Zealand
-
GlaxoSmithKlineCompletedFibrosis | Chronic Hepatitis B | Hepatitis B, Chronic | CirrhosisTaiwan, Korea, Republic of, Singapore, Hong Kong, Vietnam
-
Assembly BiosciencesCompletedChronic Hepatitis BSingapore, Hong Kong, Bulgaria, Moldova, Republic of, New Zealand, Romania
-
Alnylam PharmaceuticalsTerminatedHepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B InfectionUnited Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong
-
GlaxoSmithKlineCompletedHepatitis BSingapore, China, Hong Kong, Japan, Korea, Republic of, Philippines
-
PfizerTerminatedHepatitis C, ChronicTaiwan, Singapore, India, Korea, Republic of, Hong Kong
-
Vir Biotechnology, Inc.CompletedChronic Hepatitis BGermany, Hong Kong, Korea, Republic of, New Zealand, Romania, Singapore, United Kingdom
-
NovartisNovartis PharmaceuticalsCompletedChronic Hepatitis BAustralia, Canada, France, United States, Taiwan, Korea, Republic of, Singapore, Thailand, China
-
Hoffmann-La RocheCompletedHepatitis B, ChronicAustralia, New Zealand, Singapore, Thailand, Taiwan, China, Bulgaria, Hong Kong
-
Pfizer's Upjohn has merged with Mylan to form Viatris...TerminatedChronic Low Back Pain With a Neuropathic ComponentMalaysia, Mexico, Brazil, Chile, Colombia, Singapore, Thailand
-
Janssen Research & Development, LLCCompletedHepatitis C, ChronicPoland, Belgium, Germany, Spain, Canada, Singapore
-
Hoffmann-La RocheCompletedChronic Hepatitis BAustralia, Hong Kong, Korea, Republic of, Taiwan, Thailand, New Zealand, Singapore
-
NovartisNovartis PharmaceuticalsCompletedChronic Hepatitis BUnited States, United Kingdom, China, Taiwan, Canada, Singapore, New Zealand, Australia, France, Israel, Thailand
-
Gilead SciencesVir Biotechnology, Inc.Active, not recruitingChronic Hepatitis BHong Kong, Korea, Republic of, Denmark, Australia, Thailand, Singapore, United Kingdom, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicHong Kong, Taiwan, Singapore, Korea, Republic of, New Zealand, France, Thailand, Russian Federation, Australia, Italy
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
Hoffmann-La RocheCompletedHepatitis B, ChronicChina, Hong Kong, Taiwan, Singapore, Korea, Republic of, New Zealand, Thailand, Brazil, Russian Federation, Australia
-
Brii Biosciences LimitedVBI Vaccines Inc.; Vir Biotechnology, Inc.CompletedHepatitis B, ChronicAustralia, China, Korea, Republic of, New Zealand, Singapore, Thailand
-
Inovio PharmaceuticalsCompletedHepatitis BAustralia, Taiwan, United States, Singapore, New Zealand, Hong Kong, Thailand, Philippines